RemeGen Co., Ltd. (SHA:688331)
China · Delayed Price · Currency is CNY 79.13
-0.64 (-0.80%)
At close: Dec 26, 2025
RemeGen Market Cap
RemeGen has a market cap or net worth of 42.5 billion as of December 26, 2025. Its market cap has increased by 145.96% in one year.
Market Cap
42.50B
Enterprise Value
43.49B
Revenue
2.23B
Ranking
n/a
PE Ratio
n/a
Stock Price
79.13
Market Cap Chart
Since November 9, 2020, RemeGen's market cap has increased from 28.53B to 42.50B, an increase of 49.00%. That is a compound annual growth rate of 8.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 24, 2025 | 42.50B | 222.97% |
| Dec 31, 2024 | 13.16B | -53.43% |
| Dec 29, 2023 | 28.26B | -23.48% |
| Dec 30, 2022 | 36.93B | 18.81% |
| Dec 31, 2021 | 31.09B | -20.67% |
| Dec 31, 2020 | 39.18B | 37.36% |
| Nov 9, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 405.29B |
| WuXi AppTec | 273.05B |
| Shenzhen Mindray Bio-Medical Electronics | 241.87B |
| Sichuan Biokin Pharmaceutical | 139.78B |
| Shanghai United Imaging Healthcare | 106.87B |
| Aier Eye Hospital Group | 103.46B |
| Zhangzhou Pientzehuang Pharmaceutical., | 102.68B |
| Yunnan Baiyao Group Co.,Ltd | 101.17B |